Moreover, within the tumour, there was a significant increase in the number of CD8 + T cells and proliferating and activated CD8 + T cells in mice treated with vaccine MPs as compared to other treatment groups indicating the decrease in tumour growth kinetics in mice treated with vaccine MPs responses (Fig. 3e, f). This evidence concerns the gene CD8A and neoplasm.